Sotera Health Company provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for the medical device, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.

Sotera Health Company

An announcement from Sotera Health ( ($SHC) ) is now available. Sotera Health Company held its 2026 annual meeting of stockholders on May 21, 2026,...

Sotera Health Shareholders Back Board, Pay and Auditor

Sotera Health ( ($SHC) ) has shared an update. On May 20, 2026, Sotera Health Company and Sotera Health Holdings, LLC amended their first lien cred...

Sotera Health Refinances Term Loans to Lower Borrowing Costs

Shaftesbury Capital ( ($GB:SHC) ) has issued an announcement. Shaftesbury Capital PLC has granted new restricted share awards to its executive dire...

Shaftesbury Capital Grants Long-Term Share Awards to Top Executives

In a report released today, Mike Prew from Jefferies reiterated a Buy rating on Shaftesbury Capital, with a price target of p176.00. Prew covers th...

Jefferies Remains a Buy on Shaftesbury Capital (SHC)

In a report released today, Max Nimmo from Deutsche Bank reiterated a Buy rating on Shaftesbury Capital, with a price target of p185.00. Nimmo cove...

Deutsche Bank  Reaffirms Their Buy Rating on Shaftesbury Capital (SHC)

Shaftesbury Capital ( ($GB:SHC) ) has issued an announcement. Shaftesbury Capital shareholders strongly backed all but one resolution at the compan...

Shaftesbury Capital Wins Strong Shareholder Backing at 2026 AGM

Sotera Health ( ($SHC) ) has issued an announcement. On May 11, 2026, Sotera Health entered into an underwriting agreement with certain selling sto...

Sotera Health Shifts to Conventional Governance After Sponsors Exit

In a report released today, Sean Dodge from BMO Capital reiterated a Buy rating on Sotera Health, with a price target of $20.00. According to TipRa...

Sotera Health (SHC) Gets a Buy from BMO Capital

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Editas Medicine (EDIT), Vertex Pharmaceuticals (VRTX...

Analysts Offer Insights on Healthcare Companies: Editas Medicine (EDIT), Vertex Pharmaceuticals (VRTX) and Sotera Health (SHC)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Relay Therapeutics (RLAY), Cigna (CI) and Sotera Hea...

Analysts Offer Insights on Healthcare Companies: Relay Therapeutics (RLAY), Cigna (CI) and Sotera Health (SHC)

Jefferies analyst Mike Prew maintained a Buy rating on Shaftesbury Capital yesterday and set a price target of p176.00. Prew covers the Real Estate...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	SHC	$15.66	-0.32%	2.31M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	SHC	$15.66	-0.3%	2.31M
3
4
5
6

SHC

SHC

Get Sotera Health Company Data in Excel

Get Sotera Health Company Data in Excel